Kulkarni Anand V, Kumar Pramod, Sharma Mithun, Sowmya T R, Talukdar Rupjyoti, Rao Padaki Nagaraj, Reddy D Nageshwar
Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India.
Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
J Clin Transl Hepatol. 2020 Mar 28;8(1):42-48. doi: 10.14218/JCTH.2019.00048. Epub 2020 Mar 26.
Annually, 10% of cirrhotic patients with ascites develop refractory ascites for which large-volume paracentesis (LVP) is a frequently used therapeutic procedure. LVP, although a safe method, is associated with circulatory dysfunction in a significant percentage of patients, which is termed paracentesis-induced circulatory dysfunction (PICD). PICD results in faster reaccumulation of ascites, hyponatremia, renal impairment, and shorter survival. PICD is diagnosed through laboratory results, with increases of >50% of baseline plasma renin activity to a value ≥4 ng/mL/h on the fifth to sixth day after paracentesis. In this review, we discuss the pathophysiology and prevention of PICD.
每年,10%的肝硬化腹水患者会发展为难治性腹水,对于此类患者,大量腹腔穿刺放液(LVP)是一种常用的治疗方法。LVP虽然是一种安全的方法,但在相当比例的患者中会导致循环功能障碍,这被称为腹腔穿刺放液诱发的循环功能障碍(PICD)。PICD会导致腹水更快重新积聚、低钠血症、肾功能损害以及生存期缩短。PICD通过实验室检查结果来诊断,即在腹腔穿刺放液后第五至六天,血浆肾素活性比基线值升高>50%,达到≥4 ng/mL/h。在本综述中,我们讨论PICD的病理生理学及预防措施。